| Global statistics on alcohol, tobacco and illicit drug use: 2017 status report A Peacock, J Leung, S Larney, S Colledge, M Hickman, J Rehm, ... Addiction 113 (10), 1905-1926, 2018 | 1018 | 2018 |
| Substitution treatment of injecting opioid users for prevention of HIV infection L Gowing, M Farrell, R Bornemann, LE Sullivan, R Ali Cochrane database of systematic reviews, 2008 | 688 | 2008 |
| Global statistics on addictive behaviours: 2014 status report LR Gowing, RL Ali, S Allsop, J Marsden, EE Turf, R West, J Witton Addiction 110 (6), 904-919, 2015 | 535 | 2015 |
| Alpha2‐adrenergic agonists for the management of opioid withdrawal L Gowing, M Farrell, R Ali, JM White Cochrane Database of Systematic Reviews, 2016 | 508 | 2016 |
| Buprenorphine for the management of opioid withdrawal L Gowing, R Ali, JM White Cochrane Database of Systematic Reviews, 2009 | 439 | 2009 |
| Psychosocial interventions for cannabis use disorder PJ Gates, P Sabioni, J Copeland, B Le Foll, L Gowing Cochrane Database of Systematic Reviews, 2016 | 353 | 2016 |
| Opioid agonist treatment for pharmaceutical opioid dependent people S Nielsen, B Larance, L Degenhardt, L Gowing, C Kehler, N Lintzeris Cochrane Database of Systematic Reviews, 2016 | 329 | 2016 |
| The health effects of ecstasy: a literature review LR Gowing, SM HENRY‐EDWARDS, RJ Irvine, RL Ali Drug and alcohol review 21 (1), 53-63, 2002 | 226 | 2002 |
| Buprenorphine for managing opioid withdrawal L Gowing, R Ali, JM White, D Mbewe Cochrane Database of Systematic Reviews, 2017 | 215* | 2017 |
| Opioid antagonists with minimal sedation for opioid withdrawal L Gowing, R Ali, JM White Cochrane Database of Systematic Reviews, 2017 | 210 | 2017 |
| Pharmacotherapies for cannabis dependence K Marshall, L Gowing, R Ali, B Le Foll Cochrane Database of Systematic Reviews, 2014 | 172 | 2014 |
| Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal L Gowing, R Ali, JM White Cochrane Database of Systematic Reviews, 2010 | 145 | 2010 |
| Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection LR Gowing, M Farrell, R Bornemann, LE Sullivan, RL Ali Journal of general internal medicine 21, 193-195, 2006 | 132 | 2006 |
| Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews L Amato, M Davoli, M Ferri, L Gowing, CA Perucci Drug and alcohol dependence 73 (3), 219-226, 2004 | 127 | 2004 |
| National guidelines for medication-assisted treatment of opioid dependence L Gowing, R Ali, A Dunlop, M Farrell, N Lintzeris Canberra: Commonwealth of Australia, 38-9, 2014 | 116 | 2014 |
| Effectiveness of drug dependence treatment in HIV prevention M Farrell, L Gowing, J Marsden, W Ling, R Ali International Journal of Drug Policy 16, 67-75, 2005 | 109 | 2005 |
| α2‐Adrenergic agonists in opioid withdrawal LR Gowing, M Farrell, RL Ali, JM White Addiction 97 (1), 49-58, 2002 | 92 | 2002 |
| Pharmacotherapies for cannabis dependence S Nielsen, L Gowing, P Sabioni, B Le Foll Cochrane Database of Systematic Reviews, 2019 | 91 | 2019 |
| Supervised dosing with a long‐acting opioid medication in the management of opioid dependence R Saulle, S Vecchi, L Gowing Cochrane Database of Systematic Reviews, 2017 | 85 | 2017 |
| National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence N Lintzeris, N Clark, A Winstock, A Dunlop, P Muhleisen, L Gowing, R Ali, ... Canberra: Commonwealth of Australia, 2006 | 81 | 2006 |
